Medindia
Why Register as Premium Member if you have Diabetes? Click Here
Medindia » Research News

Why Not All Obese Patients Develop Type 2 Diabetes?

by Dr. Jayashree on June 5, 2022 at 12:08 AM
Listen to this News

A new analytical method that sheds light on an enduring mystery regarding type 2 diabetes: Why some obese patients develop the disease and others don't?


Type 2 diabetes is a serious metabolic disease that affects roughly one in 10 Americans. Formerly known as adult-onset diabetes, it is a chronic condition affecting the way the body metabolizes glucose, a sugar that's a key source of energy. This type of diabetes is frequently associated with obesity.

Link Between Diabetes and Obesity

For some patients, that means their body does not properly respond to insulin - it resists the effects of insulin, the hormone produced by the pancreas that opens the door for sugar to enter cells.

‘Treatments that modify a patient�s microbiota in ways that target insulin resistance in adipose tissue macrophage cells could be a new therapeutic strategy for type 2 diabetes.’

In the later disease stages, when the pancreas is exhausted, patients don't produce enough insulin to maintain normal glucose levels.

In either case, sugar builds up in the bloodstream and, if left untreated, the effect impairs many major organs, sometimes to disabling or life-threatening degrees. A key risk factor for type 2 diabetes is being overweight, often a result of eating too much fat and sugar in combination with low physical activity.

Andrey Morgun and Natalia Shulzhenko of OSU and Giorgio Trinchieri of the National Cancer Institute developed a novel analytical technique, multi-organ network analysis, to explore the mechanisms behind early-stage systemic insulin resistance.

Which Organs, Biological Pathways and Genes are Playing Roles?

The study findings show that a particular type of gut microbe leads to white adipose tissue containing macrophage cells - large cells that are part of the immune system - associated with insulin resistance. These findings were published in the Journal of Experimental Medicine.

"Our experiments and analysis predict that a high-fat/high-sugar diet primarily acts in white adipose tissue by driving microbiota-related damage to the energy synthesis process, leading to systemic insulin resistance," said Morgun, associate professor of pharmaceutical sciences in the OSU College of Pharmacy.

The human gut microbiome features more than 10 trillion microbial cells from about 1,000 different bacterial species.

Earlier research developed a computational method, transkingdom network analysis, that predicts specific types of bacteria controlling the expression of mammalian genes connected to specific medical conditions such as diabetes.

The so-called western diet high in saturated fats and refined sugars is one of the primary factors. But gut bacteria have an important role to play in mediating the effects of diet.

They also conducted experiments in mice, looking at the intestine, liver, muscle, and white adipose tissue, and examined the molecular signature - which genes were being expressed - of white adipose tissue macrophages in obese human patients.

Diabetes induced by the western diet is characterized by microbiota-dependent mitochondrial damage. Adipose tissue has a predominant role in systemic insulin resistance, and we characterized the gene expression program and the key master regulator of adipose tissue macrophages that are associated with insulin resistance.

They discovered oscillibacter is likely not the only microbial regulator for the expression of the key gene they identified - Mmp12 - and that the Mmp12 pathway, while instrumental, is probably not the only important pathway, depending on which gut microbes are present.



Source: Medindia

View Non AMP Site | Back to top ↑